HORSHAM, Pa., Aug. 12, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release second quarter financial results on Thursday, August 13, after the market close. MELA Sciences President and Chief Executive Officer, Michael Stewart, and Robert W. Cook, Chief Financial Officer, will host a conference call at 4:30pm Eastern Time to review the Company's progress and answer questions.
| Conference Call Details: | |
| Date: | Thursday, August 13 |
| Time: | 4:30pm Eastern Time |
| Toll Free: | 888-337-8169 |
| International: | 719-457-2689 |
| Passcode: | 3537662 |
| Webcast: | http://public.viavid.com/player/index.php?id=115368 |
| Replays, available through August 27, 2015 | |
| Toll Free: | 877-870-5176 |
| International: | 858-384-5517 |
| Replay PIN: | 3537662 |
About MELA Sciences, Inc. (www.melasciences.com)
MELA Sciences is a medical technology company focused on the dermatology market. Through its acquisition of the XTRAC and VTRAC businesses, MELA Sciences markets those products for the treatment of psoriasis, vitiligo and other skin conditions. The Company is also in the early commercialization stages of the MelaFind® system, an innovative software-driven technology that provides additional information to dermatologists in the management of melanoma skin cancer.